Creative Planning Acquires 2,333 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Creative Planning increased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 7.2% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 34,574 shares of the company’s stock after buying an additional 2,333 shares during the period. Creative Planning’s holdings in HCA Healthcare were worth $11,108,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the stock. CreativeOne Wealth LLC bought a new position in HCA Healthcare in the 1st quarter worth about $231,000. New Mexico Educational Retirement Board raised its holdings in shares of HCA Healthcare by 29.9% during the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock valued at $4,636,000 after purchasing an additional 3,200 shares during the last quarter. Kingswood Wealth Advisors LLC bought a new stake in shares of HCA Healthcare in the first quarter worth $566,000. Teachers Retirement System of The State of Kentucky raised its position in HCA Healthcare by 15.6% in the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 199,209 shares of the company’s stock worth $53,922,000 after acquiring an additional 26,919 shares during the period. Finally, Brave Warrior Advisors LLC grew its holdings in HCA Healthcare by 182.1% during the fourth quarter. Brave Warrior Advisors LLC now owns 3,873 shares of the company’s stock valued at $1,048,000 after purchasing an additional 2,500 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of analyst reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday. Truist Financial boosted their target price on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. UBS Group boosted their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Finally, Barclays increased their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $359.89.

Insiders Place Their Bets

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock valued at $6,407,273 in the last ninety days. Insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Down 0.2 %

NYSE HCA opened at $405.45 on Wednesday. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $409.42. The company has a market cap of $106.19 billion, a P/E ratio of 20.21, a P/E/G ratio of 1.52 and a beta of 1.67. The business has a fifty day moving average price of $381.85 and a 200 day moving average price of $344.10. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same period last year, the company earned $4.29 EPS. The company’s quarterly revenue was up 10.3% on a year-over-year basis. Research analysts anticipate that HCA Healthcare, Inc. will post 22.46 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date was Monday, September 16th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.